Gyrus in the news
Gyrus Capital Acquires a Majority Stake In ACBC
Gyrus Capital, a European investment firm dedicated to transformational investments in the healthcare and sustainability sectors, is pleased to announce the acquisition of ACBC (Anything Can Be Changed), a Circular Science company and certified B Corp, recognised as the leading independent sustainability service provider and innovator, specialising in advanced R&D, product innovation, and sustainable, circular solutions for the fashion and lifestyle industries.
Gyrus Capital investment into Neo Medical
Neo Medical Secures Landmark Equity Investment of $68 million to Accelerate Global Growth in Spine Surgery
LRE Medical Announces Appointment of New Chief Executive Officer
Munich, Germany – LRE Medical, a leading CDMO providing advanced diagnostic and life-science solutions, is pleased to announce the appointment of Dr. Klaus Lun as its new Chief Executive Officer, effective November 1, 2024. This strategic appointment is backed by Gyrus Capital, a prominent private equity firm specializing in transformational investments in healthcare and sustainability sectors.
Gyrus is delighted to share its inaugural 2023 Sustainability Report
The Gyrus mission is to generate exceptional and consistent investment returns by investing in and supporting businesses that operate in the healthcare and sustainability sectors – typically family/founder owned companies and corporate carve-outs…
Accenture Completes Acquisition of lntellera Consulting
Accenture has completed the acquisition of lntellera Consulting, one of Italy's main providers of consultancy services focused on public sector innovation.
Gyrus Capital Agrees to Sell Intellera to Accenture (NYSE: ACN)
Accenture (NYSE: ACN) has agreed to acquire Intellera Consulting, an Italian consultancy firm operating in the public administration and healthcare sectors. The acquisition aligns with Accenture’s ongoing focus on helping Italian public service organizations enhance and transform their citizen services.
Essential Pharma acquires Renaissance Pharma Ltd with its Clinical Stage Immunotherapy for the Treatment of High-Risk Neuroblastoma
Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically differentiated, niche pharmaceutical products across key therapeutic areas, announces that it has completed the acquisition of the entire issued share capital of Renaissance Pharma Ltd…
Gyrus Capital holds final close on Gyrus Capital Fund II
Gyrus Capital S.A. (“Gyrus” or the “Firm”) an investment firm dedicated to investments in the healthcare and sustainability sectors, today announced the final closing of Gyrus Capital Fund II (“Fund II”), raising €310 million and surpassing the €215 million raised for Gyrus Fund I (2021). Fund II consists of the Principal Fund and an open-ended Co-investment vehicle, allowing the Firm to make larger investments. With the close of Fund II, total funds raised since inception (November 2018) exceeds €750 million.
Intellera Consulting acquires Trust4Value to grow on Artificial Intelligence and Machine Learning
Intellera Consulting acquires Trust4Value (T4V), a company specialized in Data Analytics and Machine Learning services that develops solutions and systems aimed at the collection and analysis of large quantities of data, applying advanced analytical models, to help institutions and businesses take their business decisions.
dss+ Acquires ADS System Safety Consulting
The acquisition adds the specialized capabilities and deep expertise of the largest U.S. consultancy dedicated to public transport system safety, system security and fire and life safety.
Gyrus Capital agrees to acquire LRE Medical from AIS Global
Gyrus Capital and AIS Global are pleased to announce that they have entered into an agreement for Gyrus Capital to acquire LRE Medical, a leading provider of complex devices and analytical instruments for the life sciences industry.
Inflexion acquires majority stake in DSS+ from Gyrus Capital
Inflexion and Gyrus Capital are pleased to announce that they have entered into an agreement for Inflexion to acquire a majority stake in dss+…